Veterinary Medicines

NEOSKILAB Solution for injection

Authorised
  • NEOSTIGMINE METHYLSULFATE
Download as PDF

Product identification

Medicine name:
NEOSKILAB Solution for injection
NEOSKILAB 1,5 mg/ml SOLUCION INYECTABLE PARA BOVINO OVINO CAPRINO Y CABALLOS
Active substance:
  • NEOSTIGMINE METHYLSULFATE
Target species:
  • Cattle
  • Sheep
  • Goat
  • Horse
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • NEOSTIGMINE METHYLSULFATE
    1.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN07AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:
  • box containing 1 vial of 25 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3988 ESP
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0389/001
Concerned member states:
  • Belgium
  • Croatia
  • Cyprus
  • Estonia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Portugal
  • Romania

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download
Spanish (PDF)
Published on: 17/03/2023
Download

Combined File of all Documents

English (PDF)
Published on: 22/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 17/03/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 17/03/2023
Download

es-puar-neoskilab-solution-for-injection-es.pdf

Spanish (PDF)
Published on: 17/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."